You are here: Industry Insights > COVID-19

News List

Celonic to Become a Long-Term Partner of the Federal Republic of Germany for Vaccine Supply b3cnewswire.com
March 28, 2022
The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and four other partners to secure the long-term supply of vaccines in Germany against Covid-19 and other pandemics...
Kingworld Medicines Group Issues Positive Profit Alert for 2021 PharmaSources.com
March 24, 2022
Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing greater health products and services in China, issued today a positive profit alert as it expects to record...
Joint Research Shows that DENSO's Microalga, Coccomyxa sp. KJ Has Virucidal Effect against COVID-19 PharmaSources.com
March 24, 2022
Chubu University, Tokai University, Tohoku University School of Medicine and DENSO Corporation have found that monogalactosyl diacylglyceride (MGDG), a component contained in the chloroplasts of a microalga...
CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021 PharmaSources.com
February 24, 2022
Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").
Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7% PharmaSources.com
February 24, 2022
Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").
China approves use of Pfizer’s COVID drug Paxlovid ExpressPharma
February 15, 2022
It is not immediately clear if China is already in talks with Pfizer to procure the pill.
G-NiiB probiotics - world's first microbiome-based immunity formulas now available at IMI prnasia
February 15, 2022
IMI - Integrated Medicine Institute, Asia's largest natural health clinic, is pleased to announce the availability of G-NiiB Immunity Pro and G-NiiB Immunity Plus probiotic formulas designed to tackle gut bacterial imbalances...
FDA grants EUA to Lilly’s bebtelovimab for Covid-19 treatment Pharmaceutical-Technology
February 15, 2022
Bebtelovimab is indicated for treating mild-to-moderate Covid-19 in adults and paediatric patients aged 12 years and above.
WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19 WorldPharmaNews
February 15, 2022
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that Actemra®/RoActemra® (tocilizumab) intravenous (IV) has been granted World Health Organization (WHO) prequalification.
Coalition formed to tackle ‘hidden pandemic’ of antibiotic resistant infections EuropeanPharmaceuticalReview
February 14, 2022
A White Paper launched by a coalition of partners spanning pharmaceuticals, MedTech and diagnostics, calls for a transformational change in the way infection is detected, monitored...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page